Cardiac Monitoring Market to Reach $36.1 Billion by 2030 | Top Key Players are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, GE HealthCare, BIOTRONIK, Asahi Kasei Corporation

The global cardiac monitoring market is poised for significant growth, with projections indicating a rise from USD 27.1 billion in 2024 to USD 36.1 billion by 2030, reflecting a compound annual growth rate (CAGR) of 4.9% during the forecast period. This expansion is primarily driven by the increasing prevalence of cardiovascular diseases (CVDs), which, according to the World Health Organization, are the leading cause of death globally, accounting for approximately 17.9 million fatalities annually.

Several factors contribute to the escalating incidence of CVDs, including high tobacco use, elevated cholesterol levels, obesity, physical inactivity, diabetes, poor dietary habits, and alcohol consumption. These lifestyle-related issues underscore the necessity for continuous cardiac health monitoring. In response, medical technology companies are introducing innovative products; for instance, Apple Watch Series 4 and newer models feature an ECG app and advanced heart rate sensors capable of detecting irregular heart rhythms and potential signs of atrial fibrillation (A-fib).

Browse detailed report analysis on: https://www.psmarketresearch.com/market-analysis/cardiac-monitoring-market

Early monitoring and diagnosis are crucial, as they can prevent the majority of CVDs. A-fib, the most common arrhythmia in clinical practice, is projected to affect 12.1 million individuals by 2030. Early detection can prevent arrhythmias, thereby increasing the demand for cardiac monitoring and rhythm management devices, which are vital for patients at high risk of cardiac arrest. The economic burden of heart diseases is expected to surpass USD 1.0 billion by 2030, highlighting the imperative for effective heart monitoring solutions.

Key Insights

Product Segmentation

Resting electrocardiogram (ECG) devices are anticipated to account for approximately 40% of the market revenue in 2024. This dominance is attributed to their efficiency in providing quick and enhanced cardiac health diagnoses compared to other monitoring devices. Additionally, mobile cardiac telemetry (MCT) systems are emerging as the fastest-growing segment, with a projected CAGR of 6% during the forecast period, due to their capability for continuous, real-time cardiac rhythm monitoring and data transmission.

Mode of Monitoring

Standard monitoring methods are expected to hold a larger market share, approximately one-third in 2024, owing to their established presence in healthcare settings and broad application in routine cardiovascular care. Conversely, ambulatory monitoring is projected to grow at a CAGR of 5.5%, driven by technological advancements, increased patient preference for remote monitoring, and the rise of telemedicine.

End-User Analysis

Hospitals are projected to generate around USD 10.0 billion in revenue in 2024, with a CAGR of 4% from 2025 to 2030. This substantial share is due to the rising prevalence of CVDs, increasing patient visits, a growing number of cardiac device implantation procedures, and the availability of reimbursement for these procedures.

Regional Insights

North America is expected to lead the market with a 35% share in 2024, driven by the high prevalence of CVDs, increased healthcare expenditure, and the availability of advanced technologies. The American Heart Association reports that approximately 82.6 million people in the U.S. have one or more CVDs, making it a leading cause of death for both men and women. The Asia-Pacific region is anticipated to experience the fastest growth, with a CAGR of 6.5% by 2030, due to rising healthcare expenditure, increasing CVD prevalence, and advancements in healthcare infrastructure.

Technological Advancements

The market is witnessing significant technological innovations, such as the integration of advanced heart rate monitoring and ECG features in wearable devices like the Fitbit Sense 3 and Apple Watch Series 9. These devices provide users with real-time cardiac data and can detect irregularities such as atrial fibrillation. Additionally, the application of artificial intelligence and machine learning is enhancing data analysis and predictive capabilities in cardiac monitoring.

Get the sample copy of this report: https://www.psmarketresearch.com/market-analysis/cardiac-monitoring-market/report-sample

Competitive Landscape

The cardiac monitoring market is consolidated, with key players focusing on product innovation and strategic collaborations. Companies are investing in research and development to introduce advanced monitoring solutions and expand their market presence. For instance, in February 2022, AliveCor Inc. launched the KardiaMobile Card, a slim and convenient personal ECG device that performs a single-lead ECG in 30 seconds and pairs with a smartphone via Bluetooth technology.

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

Contact:
Chandra Mohan
AVP - Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://psintelligence.blogspot.com

This release was published on openPR.